Skip to main content
. 2023 Sep 9;45(2):573–583. doi: 10.1007/s10072-023-07001-6

Table 3.

Change in UPDRS Total and Motor score after 12 months of treatment with safinamide

12-months FUP vs baseline
(N = 363)
UPDRS: Change in total scores (subscales I, II, and III)  <  = −4.3 points 137 (37.7%)
 > −4.3 points* 210 (57.9%)
NA 16 (4.4%)
UPDRS Part III: Change in motor examination score  <  = −2.5 points 156 (43.0%)
 > −2.5 points* 197 (54.3%)
NA 10 (2.8%)

FUP Follow-up; NA Not available; *An increase in UPDRS Total score > 4.3 points and in UPDRS Part III > 2.5 points was considered as clinically significant according to Shulman et al. [14]. UPDRS, Unified Parkinson’s Disease Rating Scale